# KURA (Kura Oncology, Inc.) - SEC EDGAR Financial Statements

> Kura Oncology, Inc. reported $79.31M in revenue and a net loss of $292.9M for the trailing twelve months ended September 30, 2026 (up 10.1% year over year), with a -394.3% operating margin.

- Canonical: https://convexityos.com/fundamentals/KURA
- Markdown: https://convexityos.com/fundamentals/KURA.md
- SEC CIK: 0001422143
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:33 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001422143&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $79.31M | +10.1% YoY |
| Operating Income | TTM | -$312.8M | -394.3% margin |
| Net Income | TTM | -$292.9M | -369.3% net margin |
| Diluted EPS | TTM | -$3.26 | Split-adjusted |
| Free Cash Flow | TTM | -$89.12M | -112.4% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $492.1M | Total debt: $25.83M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $67.48M | $53.88M | $0 | -- | -- | -- | -- | -- | -- | -- |
| Research & Development | $251.1M | $170.0M | $115.2M | $92.81M | $84.72M | $60.40M | $47.83M | $46.79M | $26.43M | -- |
| Selling, General & Admin | $120.0M | $77.11M | $50.57M | -- | -- | -- | -- | -- | -- | -- |
| Total Operating Expenses | $371.1M | $247.1M | $165.8M | $139.9M | $131.3M | $91.90M | $67.48M | $62.88M | $36.08M | $28.37M |
| **Operating Income** | -$303.6M | -$193.2M | -$165.8M | -$139.9M | -- | -- | -- | -- | -- | -- |
| **EBITDA** | -$302.6M | -$192.3M | -$165.0M | -$139.1M | -- | -- | -- | -- | -- | -- |
| Interest Income | -- | -- | -- | -- | -- | -- | -- | -- | $751K | $499K |
| Interest Expense | $1.51M | $1.62M | $1.55M | $229K | $414K | $578K | $580K | $970K | $888K | $577K |
| Income Before Tax | -$278.4M | -$172.0M | -$152.6M | -$135.8M | -- | -- | -- | -- | -- | -- |
| Income Tax Expense | $297K | $2.02M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$278.7M | -$174.0M | -$152.6M | -$135.8M | -$130.5M | -$89.62M | -$63.14M | -$60.45M | -$35.43M | -$27.56M |
| Basic EPS | -$3.18 | -$2.02 | -$2.08 | -$2.03 | -$1.97 | -$1.69 | -$1.51 | -$1.72 | -$1.52 | -$1.47 |
| **Diluted EPS** | -$3.18 | -$2.02 | -$2.08 | -$2.03 | -$1.97 | -$1.69 | -$1.51 | -$1.72 | -$1.52 | -$1.47 |
| Basic Shares Outstanding | 87.7M | 86.2M | 73.2M | 67.0M | 66.4M | 53.1M | 41.9M | 35.2M | 23.2M | 18.7M |
| Diluted Shares Outstanding | 87.7M | 86.2M | 73.2M | 67.0M | 66.4M | 53.1M | 41.9M | 35.2M | 23.2M | 18.7M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $22.84M | $20.87M | $18.27M | $17.34M | $20.75M | $15.29M | $14.11M | -- |
| Cost of Revenue | $371K | $243K | $262K | -- | -- | -- | -- | -- |
| **Gross Profit** | $22.47M | $20.63M | $18.00M | -- | -- | -- | -- | -- |
| Research & Development | $66.88M | $61.89M | $65.26M | $64.41M | $67.91M | $62.78M | $55.97M | $52.27M |
| Selling, General & Admin | $30.25M | $31.75M | $31.55M | $39.14M | $32.84M | $25.17M | $22.84M | -- |
| Total Operating Expenses | -- | -- | -- | $103.6M | $100.7M | $87.95M | $78.81M | $76.34M |
| **Operating Income** | -$74.66M | -$73.01M | -$78.81M | -$86.27M | -$80.00M | -$72.67M | -$64.70M | -$22.45M |
| **EBITDA** | -$74.33M | -$72.64M | -$78.46M | -$85.86M | -$79.83M | -$72.44M | -$64.46M | -$22.25M |
| Interest Expense | $350K | $345K | $336K | $346K | $393K | $391K | $382K | $403K |
| Income Before Tax | -$70.22M | -$68.32M | -$73.33M | -$80.93M | -$74.12M | -$66.12M | -$57.20M | -$17.20M |
| Income Tax Expense | $0 | $5.0K | $8.0K | $71K | $0 | $0 | $226K | -- |
| **Net Income** | -$70.22M | -$68.33M | -$73.33M | -$81.00M | -$74.12M | -$66.12M | -$57.43M | -$19.22M |
| Basic EPS | -$0.78 | -$0.77 | -$0.83 | -- | -$0.85 | -$0.75 | -$0.66 | -- |
| **Diluted EPS** | -$0.78 | -$0.77 | -$0.83 | -- | -$0.85 | -$0.75 | -$0.66 | -- |
| Basic Shares Outstanding | 89.8M | 88.9M | 88.6M | -- | 87.6M | 87.6M | 87.4M | -- |
| Diluted Shares Outstanding | 89.8M | 88.9M | 88.6M | -- | 87.6M | 87.6M | 87.4M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $149.1M | $224.5M | $37.32M | $51.80M | $90.67M | $325.5M | $26.14M | $16.12M | $11.43M | $9.72M |
| Short-Term Investments | $518.1M | $502.9M | $386.6M | $386.2M | $427.3M | $307.8M | $210.8M | $162.9M | $81.71M | -- |
| **Cash & Short-Term Investments** | $667.2M | $727.4M | $424.0M | $438.0M | $518.0M | $633.3M | $236.9M | $179.0M | $93.14M | $9.72M |
| Accounts Receivable, Net | $8.80M | $2.06M | -- | -- | -- | -- | -- | -- | -- | -- |
| Inventory | $413K | $0 | -- | -- | -- | -- | -- | -- | -- | -- |
| **Total Current Assets** | $708.7M | $744.8M | $432.5M | $446.4M | $522.3M | $637.3M | $239.6M | $181.2M | $94.64M | $68.81M |
| Property, Plant & Equipment, Net | $7.86M | $1.68M | $1.86M | $2.54M | $2.67M | $2.02M | $44K | -- | $10K | $40K |
| Other Non-Current Assets | $14.54M | $7.84M | $7.60M | $3.50M | $3.31M | $1.35M | $2.09M | $1.18M | $1.20M | $971K |
| **Total Non-Current Assets** | $29.70M | $15.33M | $16.45M | $9.88M | $11.76M | $9.92M | $2.37M | $1.18M | $1.21M | $1.01M |
| **Total Assets** | $738.4M | $760.2M | $448.9M | $456.3M | $534.1M | $647.2M | $242.0M | $182.4M | $95.85M | $69.82M |
| Accounts Payable | $5.02M | $1.47M | $2.30M | $1.53M | $3.24M | $2.75M | $3.53M | $3.94M | $1.25M | $638K |
| Short-Term Debt | $0 | $2.61M | -- | -- | -- | $3.00M | $250K | -- | $1.53M | -- |
| Deferred Revenue (Current) | $48.98M | $24.27M | -- | -- | -- | -- | -- | -- | -- | -- |
| **Total Current Liabilities** | $117.0M | $78.71M | $35.26M | $24.06M | $22.45M | $26.02M | $15.56M | $13.62M | $10.03M | $5.45M |
| Long-Term Debt | $9.71M | $6.92M | $9.33M | $9.16M | -- | $4.25M | $7.25M | $7.50M | $5.57M | $7.32M |
| Deferred Revenue (Non-Current) | $424.9M | $253.9M | -- | -- | -- | -- | -- | -- | -- | -- |
| Other Non-Current Liabilities | $3.17M | $1.79M | $705K | $265K | $375K | $395K | $377K | $279K | $388K | $170K |
| **Total Non-Current Liabilities** | $447.3M | $267.8M | $16.40M | $11.97M | $4.99M | $10.28M | $7.63M | $7.78M | $5.96M | $7.49M |
| **Total Liabilities** | $564.2M | $346.5M | $51.66M | $36.03M | $27.44M | $36.31M | $23.19M | $21.39M | $15.99M | $12.95M |
| **Total Debt (incl. Leases)** | $20.46M | $16.59M | $17.20M | $14.02M | $6.88M | $14.95M | $7.80M | $7.50M | $7.10M | $7.32M |
| Common Stock | $9.0K | $8.0K | $7.0K | $7.0K | $7.0K | $7.0K | $5.0K | $4.0K | $3.0K | $2.0K |
| Retained Earnings | -$1.17B | -$895.4M | -$721.4M | -$568.8M | -$433.0M | -$302.5M | -$212.9M | -$149.7M | -$89.29M | -$53.86M |
| Accumulated Other Comp. Income | $1.02M | $764K | -$1.27M | -$8.03M | -$1.79M | $46K | $331K | -$131K | -$49K | -$18K |
| **Total Stockholders' Equity** | $174.1M | $413.6M | $397.3M | $420.3M | $506.6M | $610.9M | $218.8M | $161.0M | $79.86M | $56.88M |
| Total Equity | $174.1M | $413.6M | $397.3M | $420.3M | $506.6M | $610.9M | $218.8M | $161.0M | $79.86M | $56.88M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $57.94M | $70.24M | $39.08M | $149.1M | $95.29M | $81.95M | $51.27M | $224.5M |
| Short-Term Investments | $434.2M | $448.8M | $541.7M | $518.1M | $454.4M | $548.8M | $606.9M | $502.9M |
| **Cash & Short-Term Investments** | $492.1M | $519.0M | $580.8M | $667.2M | $549.7M | $630.7M | $658.2M | $727.4M |
| Accounts Receivable, Net | $14.48M | $9.45M | $9.35M | $8.80M | $35.94M | $4.57M | $48.75M | $2.06M |
| Inventory | $4.98M | $2.48M | $843K | $413K | -- | -- | -- | $0 |
| **Total Current Assets** | $534.7M | $559.4M | $623.8M | $708.7M | $620.7M | $660.1M | $724.2M | $744.8M |
| Property, Plant & Equipment, Net | $7.46M | $7.59M | $7.61M | $7.86M | $7.40M | $3.91M | $2.35M | $1.68M |
| Other Non-Current Assets | $17.43M | $13.73M | $13.99M | $14.54M | $13.78M | $10.57M | $9.08M | $7.84M |
| **Total Non-Current Assets** | $31.80M | $28.35M | $28.77M | $29.70M | $28.72M | $22.35M | $19.57M | $15.33M |
| **Total Assets** | $566.5M | $587.8M | $652.6M | $738.4M | $649.4M | $682.4M | $743.8M | $760.2M |
| Accounts Payable | $8.13M | $2.39M | $7.04M | $5.02M | $4.67M | $1.70M | $4.61M | $1.47M |
| Short-Term Debt | $8.53M | $4.22M | -- | $0 | $4.34M | $3.11M | $1.92M | $2.61M |
| Deferred Revenue (Current) | $63.49M | $55.48M | $47.70M | $48.98M | $48.75M | $49.44M | $40.85M | $24.27M |
| **Total Current Liabilities** | $148.7M | $118.2M | $101.5M | $117.0M | $121.3M | $107.2M | $89.77M | $78.71M |
| Long-Term Debt | $1.30M | $5.57M | $9.75M | $9.71M | $5.34M | $6.51M | $7.65M | $6.92M |
| Deferred Revenue (Non-Current) | $380.4M | $398.6M | $416.7M | $424.9M | $268.9M | $252.5M | $271.9M | $253.9M |
| Other Non-Current Liabilities | $3.98M | $3.62M | $3.44M | $3.17M | $2.98M | $2.60M | $2.14M | $1.79M |
| **Total Non-Current Liabilities** | $399.8M | $421.2M | $443.2M | $447.3M | $285.5M | $269.8M | $289.6M | $267.8M |
| **Total Liabilities** | $548.5M | $539.4M | $544.7M | $564.2M | $406.8M | $376.9M | $379.4M | $346.5M |
| **Total Debt (incl. Leases)** | $25.83M | $24.45M | $24.27M | $20.46M | $19.47M | $19.47M | $19.35M | $16.59M |
| Common Stock | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $8.0K | $8.0K |
| Retained Earnings | -$1.39B | -$1.32B | -$1.25B | -$1.17B | -$1.09B | -$1.02B | -$952.9M | -$895.4M |
| Accumulated Other Comp. Income | -- | -- | -- | $1.02M | -- | $711K | $974K | $764K |
| **Total Stockholders' Equity** | $17.96M | $48.43M | $107.9M | $174.1M | $242.5M | $305.5M | $364.4M | $413.6M |
| Total Equity | $17.96M | $48.43M | $107.9M | $174.1M | $242.5M | $305.5M | $364.4M | $413.6M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$278.7M | -$174.0M | -$152.6M | -$135.8M | -$130.5M | -$89.62M | -$63.14M | -$60.45M | -$35.43M | -$27.56M |
| Depreciation & Amortization | $1.03M | $848K | $849K | $759K | $558K | $194K | $0 | $10K | $30K | $31K |
| Stock-Based Compensation | $37.11M | $33.90M | $28.08M | $26.32M | $23.58M | $12.81M | $9.41M | $8.65M | $4.54M | $2.09M |
| Change in Receivables | -$6.74M | -$2.06M | $0 | -- | -- | -- | -- | -- | -- | -- |
| Change in Inventory | -$413K | $0 | $0 | -- | -- | -- | -- | -- | -- | -- |
| Change in Payables | $4.50M | -$1.63M | -$924K | -- | -- | -- | -- | -- | -- | -- |
| **Operating Cash Flow** | -$64.06M | $134.3M | -$124.8M | -$110.1M | -$104.6M | -$69.83M | -$54.76M | -$48.66M | -$28.44M | -$25.35M |
| Capital Expenditure | -$6.64M | -$472K | -$168K | -$626K | -$1.15M | -$2.17M | -- | -- | -- | -- |
| **Free Cash Flow** | -$70.70M | $133.8M | -$125.0M | -$110.7M | -$105.7M | -$72.00M | -- | -- | -- | -- |
| Purchases of Investments | -- | -- | -$409.8M | -$270.7M | -$445.7M | -$321.0M | -$227.6M | -$237.4M | -$100.6M | -$56.43M |
| **Investing Cash Flow** | -$13.10M | -$101.6M | $15.56M | $32.63M | -$126.8M | -$99.94M | -$46.33M | -$79.30M | -$23.42M | $12.18M |
| Common Stock Issued | -- | -- | -- | $24.72M | -- | $459.3M | $108.2M | $132.2M | $53.68M | -- |
| **Financing Cash Flow** | $1.79M | $154.4M | $94.78M | $38.56M | -$3.44M | $469.3M | $111.1M | $132.6M | $53.57M | $7.45M |
| **Net Change in Cash** | -$75.36M | $187.1M | -$14.48M | -$38.87M | -$234.8M | $299.6M | $10.02M | $4.69M | $1.71M | -$5.72M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$70.22M | -$68.33M | -$73.33M | -$81.00M | -$74.12M | -$66.12M | -$57.43M | -$19.22M |
| Depreciation & Amortization | $329K | $369K | $355K | $403K | $164K | $224K | $241K | $204K |
| Stock-Based Compensation | $8.17M | $8.21M | $8.42M | $11.35M | $10.96M | $6.95M | $7.84M | $8.63M |
| Change in Receivables | -$5.04M | -$98K | -$544K | $27.13M | -$31.36M | $44.17M | -$46.69M | -- |
| Change in Inventory | -$2.50M | -$1.64M | -$430K | -- | -- | -- | -- | -- |
| Change in Payables | $5.70M | -$4.65M | $2.03M | $1.30M | $2.97M | -$2.91M | $3.14M | -- |
| **Operating Cash Flow** | -$54.44M | -$62.55M | -$85.85M | $117.3M | -$80.63M | -$28.78M | -$71.93M | $269.1M |
| Capital Expenditure | -$445K | -$656K | -$128K | -$2.32M | -$2.57M | -$1.46M | -$292K | -$372K |
| **Free Cash Flow** | -$54.89M | -$63.20M | -$85.98M | $115.0M | -$83.19M | -$30.23M | -$72.22M | $268.8M |
| **Investing Cash Flow** | $9.60M | $92.21M | -$24.23M | -$64.60M | $93.97M | $58.94M | -$101.4M | -$94.95M |
| **Financing Cash Flow** | $32.54M | $1.50M | $69K | $1.14M | $0 | $515K | $143K | $806K |
| **Net Change in Cash** | -$12.30M | $31.16M | -$110.0M | $53.81M | $13.34M | $30.68M | -$173.2M | $175.0M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -449.9% | -358.5% | -- | -- | -- | -- | -- | -- | -- | -- |
| **Net Profit Margin** | -412.9% | -322.9% | -- | -- | -- | -- | -- | -- | -- | -- |
| Return on Equity (ROE) | -160.0% | -42.1% | -38.4% | -32.3% | -25.8% | -14.7% | -28.9% | -37.5% | -44.4% | -48.5% |
| Return on Assets (ROA) | -37.7% | -22.9% | -34.0% | -29.8% | -24.4% | -13.8% | -26.1% | -33.1% | -37.0% | -39.5% |
| Current Ratio | 6.06x | 9.46x | 12.26x | 18.56x | 23.26x | 24.49x | 15.39x | 13.31x | 9.43x | 12.62x |
| Quick Ratio | 6.05x | 9.46x | 12.02x | 18.21x | 23.07x | 24.34x | 15.22x | 13.15x | 9.29x | 1.78x |
| Debt to Equity | 0.12x | 0.04x | 0.04x | 0.03x | 0.01x | 0.02x | 0.04x | 0.05x | 0.09x | 0.13x |
| **Revenue Growth (YoY)** | +25.2% | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -147.7% | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -152.8% | -- | -- | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -394.3% | -411.9% | -443.5% | -449.9% | -- | -- | -- | -- |
| **Net Profit Margin** | -369.3% | -384.3% | -411.2% | -412.9% | -- | -- | -- | -- |
| Return on Equity (ROE) | -1630.7% | -612.8% | -273.0% | -160.0% | -89.4% | -64.5% | -49.9% | -42.1% |
| Return on Assets (ROA) | -51.7% | -50.5% | -45.1% | -37.7% | -33.4% | -28.9% | -24.5% | -22.9% |
| Current Ratio | 3.60x | 4.73x | 6.15x | 6.06x | 5.12x | 6.16x | 8.07x | 9.46x |
| Quick Ratio | 3.56x | 4.71x | 6.14x | 6.05x | 4.83x | 5.93x | 7.88x | 9.46x |
| Debt to Equity | 1.44x | 0.50x | 0.22x | 0.12x | 0.08x | 0.06x | 0.05x | 0.04x |
| **Revenue Growth (YoY)** | +10.1% | +36.5% | +29.5% | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -56.4% | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -57.2% | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
